Anke Hildebrandt

Anke Hildebrandt is an accomplished professional in regulatory affairs with extensive experience in the pharmaceutical industry. Currently serving as Executive Director of Regulatory Affairs at HOOKIPA Pharma Inc. since April 2020, Anke previously held significant roles at Takeda, including Director of Regulatory Affairs and EU RA team lead for hematology at Baxalta Innovations GmbH. Anke's career encompasses positions at Shire, Baxalta, Merck, Astellas Europe, Sandoz, Sanofi, and GSK, showcasing a strong background in developing regulatory strategies, leading submission teams, and ensuring high-quality regulatory documentation across multiple therapeutic areas. Anke holds advanced degrees in Pharmacology and Pharmacy from the University of Vienna and a post-graduate education in Business and Legal Sciences from Technische Universität Wien.